Bupivacaine Hydrochloride for Pain Control in Cutaneous Surgery
Status:
Not yet recruiting
Trial end date:
2023-02-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to determine if the addition of bupivacaine HCl injections will
improve pain control after skin surgery.
This is a randomized clinical trial. Approximately 100 participants will be randomized to
receive either bupivacaine HCl or saline injections to help with the postsurgical pain.
Patients will be provided with a take-home journal to complete indicating when and how much
pain medication they required for the 3 days immediately following surgery. Participants will
return the journal in-person at a follow up visit 7-21 days post-op. This study was a pilot
study designed to determine the feasibility of this procedure.
Subjects currently living in the Chicago metropolitan area and meet inclusion/exclusion
criteria will be invited and considered for enrollment.